Top Markets
#1 Orochi Network Orochi Network +71.79%
#2 Bitway Bitway +26.98%
#3 Audiera Audiera +24.63%
#4 RSK Infrastructure Framework RSK Infrastructure Framework +18.60%
#5 Pharos Pharos +15.97%
#6 SOON SOON +15.75%
#7 Cheems Token Cheems Token +14.21%
#8 Taiko Taiko +13.85%
#9 Manadia Manadia +13.47%
#10 ROLL ROLL +13.27%
Coin of the day
Orochi Network Orochi Network
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Kedudukan dalam Saham #72
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Harga Saham
$50.93
Modal Pasaran
$226.32B
Perubahan (1 hari)
2.54%
Perubahan (1 tahun)
-26.19%
Negara
DK
Perdagangan Novo Nordisk A/S (NVO)

Kategori

Healthcare
EPS untuk Novo Nordisk A/S (NVO)
EPS setakat March 2026 TTM: $4.36
Menurut laporan kewangan terkini dan harga saham Novo Nordisk A/S, EPS semasa syarikat (TTM) adalah $4.36. Pada akhir tahun 2024, syarikat mempunyai EPS sebanyak $3.16 peningkatan berbanding EPS tahun 2023 iaitu $2.76.
Sejarah EPS untuk Novo Nordisk A/S dari 2000 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
2026 (TTM) $4.36 20.40%
2025 $3.62 14.52%
2024 $3.16 14.42%
2023 $2.76 56.72%
2022 $1.76 10.96%
2021 $1.59 7.30%
2020 $1.48 20.24%
2019 $1.23 0.54%
2018 $1.23 -1.37%
2017 $1.24 16.81%
2016 $1.06 7.67%
2015 $0.99 20.28%
2014 $0.82 -5.24%
2013 $0.87 25.34%
2012 $0.69 31.26%
2011 $0.53 18.44%
2010 $0.44 28.33%
2009 $0.35 18.86%
2008 $0.29 9.87%
2007 $0.27 50.37%
2006 $0.18 25.27%
2005 $0.14 2.77%
2004 $0.14 13.97%
2003 $0.12 44.42%
2002 $0.08 24.70%
2001 $0.07 19.07%
2000 $0.06 0.00%
EPS untuk syarikat atau pesaing yang serupa
Syarikat EPS Perbezaan EPS Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.01 290.29%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $42.53 875.84%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.62 120.75%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $23.88 447.92%
NL
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
ALNY.US
 $4.36 0.04%
US